Quick Answer
Organogenesis Holdings Inc. reported Net Income Loss of $37.03 million for the year ending 2025.
- Organogenesis Holdings Inc. showed an increase of +4,201.0% in Net Income Loss from 2024 to 2025.
- This data is from Organogenesis Holdings Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 11 years of available data (2015 to 2025), Organogenesis Holdings Inc.'s Net Income Loss has grown by 147,274.3%.
- Historical annual values: Fiscal year 2025: $37.03 million | Fiscal year 2024: $861.0 thousand | Fiscal year 2023: $4.95 million | Fiscal year 2022: $15.53 million | Fiscal year 2021: $94.20 million | Fiscal year 2020: $17.23 million | Fiscal year 2019: -$38.71 million | Fiscal year 2018: -$64.83 million | Fiscal year 2017: -$8.39 million | Fiscal year 2016: -$16.99 million | Fiscal year 2015: -$25.2 thousand.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: